VX-670 Solution for Injection/Infusion
VX-24-670-101
Phase 2 small_molecule active
Quick answer
VX-670 Solution for Injection/Infusion for Myotonic Dystrophy is a Phase 2 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Myotonic Dystrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active